This article is published in the forthcoming issue.

Effect on MDA-MB231 human breast cancer cell line treated with bilberry (Vaccinium myrtillus) using Annexin V and AgNOR staining

MDA-MB231 treated with blueberry using Annexin V and AgNOR staining

Authors

Keywords:

MDA-MB-231, bilberry, apoptosis, in vitro

Abstract

Background/Aim: Cancer has become a prevalent disease, emerging as one of the major chronic health issues today. Currently, common treatments against cancer include chemotherapy, radiotherapy, surgery, and the use of chemically synthesized drugs. However, despite significant advancements in diagnostic methods and treatments, drug resistance and metastasis remain primary hurdles to successful cancer therapy. Consequently, attention has been shifted towards exploring alternative treatments and therapies against cancer. This study sought to examine the time and dose-dependent effects of blueberry (Vaccinium myrtillus L) on MDA-MB-231 cell lines.

Methods: The study used the MDA-MB231 breast cancer cell line. We established three groups: control, 40 µl/ml bilberry, and 80 µl/ml bilberry, which were incubated at 37°C and 5% CO2 for 24 and 48 h, respectively. After incubation, we examined the viability, apoptosis, and cell cycle of MDA-MB-231 cells with the Muse Cell Analyzer and assessed the status of nucleolar organizer region (NOR) proteins via silver nitrate (AgNOR) staining.

Results: Bilberry extracts were found to enhance apoptosis and exhibit a cytotoxic effect, thereby reducing cell proliferation in MDA-MB-231 cells after 24 and 48 h of culture. There was notably increased apoptosis at concentrations of 40 µl and 80 µl. Moreover, after 48 h of incubation, a significant difference emerged between the control and 40 µg/ml bilberry samples, notably in the average AgNOR count and the total AgNOR area/total nuclear area ratio.

Conclusion: Our study suggests that blueberries may be a potential therapeutic candidate for cancer treatment, thereby potentially enriching cancer research.

Downloads

Download data is not yet available.

References

Kubczak M, Szustka A, Rogalińska M. Molecular Targets of Natural Compounds with Anti-Cancer Properties. Int J Mol Sci. 2021;22(24):13659. doi: 10.3390/ijms222413659. Review. PubMed PMID: 34948455; PubMed Central PMCID: PMC8708931.

Dehelean CA, Marcovici I, Soica C, Mioc M, Coricovac D, Iurciuc S, et al. Plant-Derived Anticancer Compounds as New Perspectives in Drug Discovery and Alternative Therapy. Molecules. 2021;19;26(4):1109. doi: 10.3390/molecules26041109. Review. PubMed PMID: 33669817; PubMed Central PMCID: PMC7922180.

Greenwell M, Rahman PK. Medicinal Plants: Their Use in Anticancer Treatment. Int J Pharm Sci Res. 2015;1;6(10):4103-12. doi: 10.13040/IJPSR.0975-8232.6(10).4103-12. PMID: 26594645; PMCID: PMC4650206.

Cragg GM, Newman DJ. Plants as a source of anti-cancer agents. J Ethnopharmacol. 2005;22;100(1-2):72-9. doi: 10.1016/j.jep.2005.05.011. Review. PubMed PMID: 16009521.

Iwamoto LH, Vendramini-Costa DB, Monteiro PA, Ruiz AL, Sousa IM, Foglio MA, et al. Anticancer and Anti-Inflammatory Activities of a Standardized Dichloromethane Extract from Piper umbellatum L. Leaves. Evid Based Complement Alternat Med. 2015; 2015:948737. doi: 10.1155/2015/948737. Epub 2015 Feb 3. PubMed PMID: 25713595; PubMed Central PMCID: PMC4332971.

Liu H, Zang C, Fenner MH, Possinger K, Elstner E. PPARgamma ligands and ATRA inhibit the invasion of human breast cancer cells in vitro. Breast Cancer Res Treat. 2003;79(1):63-74. doi: 10.1023/a:1023366117157. PubMed PMID: 12779083.

Wahle KW, Brown I, Rotondo D, Heys SD. Plant phenolics in the prevention and treatment of cancer. Adv Exp Med Biol. 2010;698:36-51. doi: 10.1007/978-1-4419-7347-4_4. Review. PubMed PMID: 21520702.

Åkerström A. Factors affecting the anthocyanidin concentration in fruits of Vaccinium myrtillus L. Doctoral Thesis Swedish University of Agricultural Sciences Umeå 2010 pp.13-14..

Babova O, Occhipinti A, Capuzzo A, Maffei ME. Extraction of bilberry (Vaccinium myrtillus) antioxidants using supercritical/subcritical CO2 and ethanol as co-solvent. The Journal of Supercritical Fluids. 2016;107:358-63. doi: 10.1016/j.supflu.2015.09.029.

Seeram NP. Berry fruits for cancer prevention: current status and future prospects. J Agric Food Chem. 2008,13;56(3):630-5. doi: 10.1021/jf072504n. Epub 2008 Jan 23. PMID: 18211019.

Stoner GD, Wang LS, Zikri N, Chen T, Hecht SS, Huang C, et al. Cancer prevention with freeze-dried berries and berry components. Semin Cancer Biol. 2007;17(5):403-10. doi: 10.1016/j.semcancer.2007.05.001. Epub 2007 May 10. Review. PubMed PMID: 17574861; PubMed Central PMCID: PMC2196225.

Wang LS, Hecht SS, Carmella SG, Yu N, Larue B, Henry C, et al. Anthocyanins in black raspberries prevent esophageal tumors in rats. Cancer prevention research (Phila). 2009;2(1):84-93. doi: 10.1158/1940-6207.CAPR-08-0155. PubMed PMID: 19139022; PubMed Central PMCID: PMC3079338.

Stoner GD, Wang LS, Seguin C, Rocha C, Stoner K, Chiu S, Kinghorn AD. Multiple berry types prevent N-nitrosomethylbenzylamine-induced esophageal cancer in rats. Pharm Res. 2010;27(6):1138-45. doi: 10.1007/s11095-010-0102-1. Epub 2010 Mar 16. PubMed PMID: 20232121; PubMed Central PMCID: PMC3016717.

Harris GK, Gupta A, Nines RG, Kresty LA, Habib SG, Frankel WL, et al. Effects of lyophilized black raspberries on azoxymethane-induced colon cancer and 8-hydroxy-2’-deoxyguanosine levels in the Fischer 344 rat. Nutr Cancer. 2001;40(2):125-33. doi: 10.1207/S15327914NC402_8. PubMed PMID: 11962247.

Balansky R, Ganchev G, Iltcheva M, Kratchanova M, Denev P, Kratchanov C, et al. Inhibition of lung tumor development by berry extracts in mice exposed to cigarette smoke. Int J Cancer. 2012;1;131(9):1991-7. doi: 10.1002/ijc.27486. Epub 2012 Mar 27. PubMed PMID: 22328465.

Duncan FJ, Martin JR, Wulff BC, Stoner GD, Tober KL, Oberyszyn TM, et al. Topical treatment with black raspberry extract reduces cutaneous UVB-induced carcinogenesis and inflammation. Cancer Prev Res (Phila). 2009;2(7):665-72. doi: 10.1158/1940-6207.CAPR-08-0193. PubMed PMID: 19584078; PubMed Central PMCID: PMC3874934.

Johnson SA, Arjmandi BH. Evidence for anti-cancer properties of blueberries: a mini-review. Anticancer Agents Med Chem. 2013;13(8):1142-8. doi: 10.2174/18715206113139990137. Review. PubMed PMID: 23387969.

Anantharaju PG, Gowda PC, Vimalambike MG, Madhunapantula SV. An overview on the role of dietary phenolics for the treatment of cancers. Nutr J. 2016;1;15(1):99. doi: 10.1186/s12937-016-0217-2. Review. PubMed PMID: 27903278; PubMed Central PMCID: PMC5131407.

Prior RL, Cao G, Martin A, Sofic E, McEwen J, O'Brien C, et al. Antioxidant capacity as influenced by total phenolic and anthocyanin content, maturity, and variety of Vaccinium species. Journal of agricultural and food chemistry 1998;46(7):2686-93. ISSN: 0021-8561. doi: 10.1021/jf980145d.

Giovanelli G, Susanna B. Comparison of polyphenolic composition and antioxidant activity of wild. Food Chemistry. 2009;112(4):903-8. doi: 10.1016/j.foodchem.2008.06.066.

Helmstädter A, Schuster N. Vaccinium myrtillus as an antidiabetic medicinal plant--research through the ages. Pharmazie. 2010;65(5):315-21. Review. PubMed PMID: 20503920.

Tracy TS, Bilberry. In: Tracy TS, Kingston RL. eds. Herbal products. forensic science and medicine. Humana Press; 2007. pp. 259-268. doi: 10.1007/978-1-59745-383-7_17.

Chu W, Cheung SCM, Lau RAW, Benzie IFF. Bilberry (Vaccinium myrtillus L.). Review. 2011;55-71. PubMed PMID: 22593936.

Zhao C, Giusti MM, Malik M, Moyer MP, Magnuson BA. Effects of commercial anthocyanin-rich extracts on colonic cancer and nontumorigenic colonic cell growth. J Agric Food Chem. 2004;6;52(20):6122-8. doi: 10.1021/jf049517a. PubMed PMID: 15453676.

Aiyer HS, Srinivasan C, Gupta RC. Dietary berries and ellagic acid diminish estrogen-mediated mammary tumorigenesis in ACI rats. Nutr Cancer. 2008;60(2):227-34. doi: 10.1080/01635580701624712. PubMed PMID: 18444155.

Zhao, Y. Berry fruit: Value-Added products for health promotion. New York: CRC Press is an imprint of Taylor & Francis Group; 2007. doi: 10.1201/9781420006148.

Faria A, Pestana D, Teixeira D, de Freitas V, Mateus N, Calhau C. Blueberry anthocyanins and pyruvic acid adducts: anticancer properties in breast cancer cell lines. Phytother Res. 2010 Dec;24(12):1862-9. doi: 10.1002/ptr.3213. PubMed PMID: 20564502.

Adams LS, Phung S, Yee N, Seeram NP, Li L, Chen S. Blueberry phytochemicals inhibit growth and metastatic potential of MDA-MB-231 breast cancer cells through modulation of the phosphatidylinositol 3-kinase pathway. Cancer Res. 2010; 1;70(9):3594-605. doi: 10.1158/0008-5472.CAN-09-3565. Epub 2010 Apr 13. PubMed PMID: 20388778; PubMed Central PMCID: PMC2862148.

Downloads

Published

2024-11-11

Issue

Section

Research Article

How to Cite

1.
Beştepe K, Nisari M, Nisari M, Uçar S, Koca FM, İnanç N. Effect on MDA-MB231 human breast cancer cell line treated with bilberry (Vaccinium myrtillus) using Annexin V and AgNOR staining: MDA-MB231 treated with blueberry using Annexin V and AgNOR staining. J Surg Med [Internet]. 2024 Nov. 11 [cited 2024 Nov. 21];8(11):180-4. Available from: https://jsurgmed.com/article/view/7678